3,4-dihydroxybenzalacetone protects against parkinson's disease-related neurotoxin 6-OHDA through Akt/Nrf2/glutathione pathway

Journal of Cellular Biochemistry

Volumn 115, Issue 1, 2014, Pages 151-160

  Gunjima, Kei ^a   Tomiyama, Ryoichi ^a   Takakura, Ken ^a   Yamada, Takashi ^a   Hashida, Koji ^a,b   Nakamura, Yutaka ^c   Konishi, Tetsuya ^c   Matsugo, Seiichi ^a   Hori, Osamu ^a,b  

^a KANAZAWA UNIVERSITY   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^c NIIGATA UNIVERSITY OF PHARMACY AND APPLIED LIFE SCIENCES   (Japan)

Author keywords

GLUTATHIONE; NEURONAL DEATH; PARKINSON'S DISEASE

Indexed keywords

3,4 DIHYDROXYBENZALACETONE; ANTIPARKINSON AGENT; BUTHIONINE SULFOXIMINE; CAFFEIC ACID; DICOUMAROL; GLUTATHIONE; NEUROTOXIN; OXIDOPAMINE; PROTEIN KINASE B; REACTIVE OXYGEN METABOLITE; TRANSCRIPTION FACTOR NRF2; UNCLASSIFIED DRUG;

ANTIOXIDANT RESPONSIVE ELEMENT; ARTICLE; CELL DEATH; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; ENZYME ACTIVATION; GLUTATHIONE METABOLISM; HUMAN; HUMAN CELL; HYDROPHOBICITY; MOLECULAR DYNAMICS; NEUROBLASTOMA CELL; NEUROPROTECTION; OXIDATIVE STRESS; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; STRUCTURE ACTIVITY RELATION; WESTERN BLOTTING;

GLUTATHIONE; NEURONAL DEATH; PARKINSON'S DISEASE;

BUTHIONINE SULFOXIMINE; CAFFEIC ACIDS; CELL LINE, TUMOR; DOSE-RESPONSE RELATIONSHIP, DRUG; GLUTATHIONE; HUMANS; NEUROBLASTOMA; NEUROPROTECTIVE AGENTS; NEUROTOXINS; NF-E2-RELATED FACTOR 2; OXIDATIVE STRESS; OXIDOPAMINE; PARKINSON DISEASE; PROTEIN TRANSPORT; PROTO-ONCOGENE PROTEINS C-AKT; REACTIVE OXYGEN SPECIES;

EID: 84887906733     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.24643     Document Type: Article

References (27)

1. Andersen JK, Mo JQ, Hom DG, Lee FY, Harnish P, Hamill RW, McNeill TH,. 1996. Effect of buthionine sulfoximine, a synthesis inhibitor of the antioxidant glutathione, on the murine nigrostriatal neurons. J Neurochem 67 (5): 2164-2171.
2. Arakawa M, Ito Y,. 2007. N-acetyl cysteine and neurodegenerative diseases: Basic and clinical pharmacology. Cerebellum 6 (4): 308-314. doi: 10.1080/14734220601142878. Epub2007 Jan 19.
3. Bizzozero OA, Ziegler JL, De Jesus G, Bolognani F,. 2006. Acute depletion of reduced glutathione causes extensive carbonylation of rat brain proteins. J Neurosci Res 83 (4): 656-667.
4. Blum D, Torch S, Lambeng N, Nissou M, Benabid AL, Sadoul R, Verna JM,. 2001. Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: Contribution to the apoptotic theory in Parkinson's disease. Prog Neurobiol 65 (2): 135-172.
5. Celli N, Dragani LK, Murzilli S, Pagliani T, Poggi A,. 2007. In vitro and in vivo stability of caffeic acid phenethyl ester, a bioactive compound of propolis. J Agric Food Chem 55 (9): 3398-3407. Epub 2007 Mar 30.
6. Dauer W, Przedborski S,. 2003. Parkinson's disease: Mechanisms and models. Neuron 39 (6): 889-909.
7. Hanrott K, Gudmunsen L, O'Neill MJ, Wonnacott S,. 2006. 6-Hydroxydopamine-induced apoptosis is mediated via extracellular auto-oxidation and caspase 3-dependent activation of protein kinase Cdelta. J Biol Chem 281 (9): 5373-5382. Epub 2005 Dec 16.
8. Kim YO, Park HW, Kim JH, Lee JY, Moon SH, Shin CS,. 2006. Anti-cancer effect and structural characterization of endo-polysaccharide from cultivated mycelia of Inonotus obliquus. Life Sci 79 (1): 72-80. Epub 2006 Feb 3.
9. Kim HG, Yoon DH, Kim CH, Shrestha B, Chang WC, Lim SY, Lee WH, Han SG, Lee JO, Lim MH, Kim GY, Choi S, Song WO, Sung JM, Hwang KC, Kim TW,. 2007. Ethanol extract of Inonotus obliquus inhibits lipopolysaccharide-induced inflammation in RAW 264.7 macrophage cells. J Med Food 10 (1): 80-89.
10. Magesh S, Chen Y, Hu L,. 2012. Small molecule modulators of Keap1-Nrf2-ARE pathway as potential preventive and therapeutic agents. Med Res Rev 32 (4): 687-726. doi: 10.1002/med.21257. Epub2012 May.
11. Mytilineou C, Kramer BC, Yabut JA,. 2002. Glutathione depletion and oxidative stress. Parkinsonism Relat Disord 8 (6): 385-387.
12. Nakajima Y, Sato Y, Konishi T,. 2007. Antioxidant small phenolic ingredients in Inonotus obliquus (persoon) Pilat (Chaga). Chem Pharm Bull (Tokyo) 55 (8): 1222-1226.
13. Nakajima Y, Nishida H, Matsugo S, Konishi T,. 2009a. Cancer cell cytotoxicity of extracts and small phenolic compounds from Chaga [Inonotus obliquus (persoon) Pilat]. J Med Food 12 (3): 501-507.
14. Nakajima Y, Nishida H, Nakamura Y, Konishi T,. 2009b. Prevention of hydrogen peroxide-induced oxidative stress in PC12 cells by 3,4- dihydroxybenzalacetone isolated from Chaga (Inonotus obliquus (persoon) Pilat). Free Radic Biol Med 47 (8): 1154-1161. Epub 2009 Jul 30.
15. Pan T, Xie W, Jankovic J, Le W,. 2005. Biological effects of pramipexole on dopaminergic neuron-associated genes: Relevance to neuroprotection. Neurosci Lett 377 (2): 106-109.
16. Park YK, Lee HB, Jeon EJ, Jung HS, Kang MH,. 2004. Chaga mushroom extract inhibits oxidative DNA damage in human lymphocytes as assessed by comet assay. Biofactors 21 (1-4): 109-112.
17. Park YM, Won JH, Kim YH, Choi JW, Park HJ, Lee KT,. 2005. In vivo and in vitro anti-inflammatory and anti-nociceptive effects of the methanol extract of Inonotus obliquus. J Ethnopharmacol 101 (1-3): 120-128.
18. Perry TL, Yong VW,. 1986. Idiopathic Parkinson's disease, progressive supranuclear palsy and glutathione metabolism in the substantia nigra of patients. Neurosci Lett 67 (3): 269-274.
19. Riederer P, Sofic E, Rausch WD, Schmidt B, Reynolds GP, Jellinger K, Youdim MB,. 1989. Transition metals, ferritin, glutathione, and ascorbic acid in Parkinsonian brains. J Neurochem 52 (2): 515-520.
20. Scapagnini G, Vasto S, Abraham NG, Caruso C, Zella D, Fabio G,. 2011. Modulation of Nrf2/ARE pathway by food polyphenols: A nutritional neuroprotective strategy for cognitive and neurodegenerative disorders. Mol Neurobiol 44 (2): 192-201. Epub 2011 Apr 19.
21. Schreiber E, Matthias P, Müller MM, Schaffner W,. 1989. Rapid detection of octamer binding proteins with "mini-extracts", prepared from a small number of cells. Nucleic Acids Res 17 (15): 6419.
22. Shashkina M, Shashkin P, Sergeev A,. 2006. Chemical and medicobiological properties of Chaga (review). Pharm Chem J. 40 (10): 560-568.
23. Sung B, Pandey MK, Nakajima Y, Nishida H, Konishi T, Chaturvedi MM, Aggarwal BB,. 2008. Identification of a novel blocker of IkappaBalpha kinase activation that enhances apoptosis and inhibits proliferation and invasion by suppressing nuclear factor-kappaB. Mol Cancer Ther 7 (1): 191-201.
24. Takahashi T, Deng Y, Maruyama W, Dostert P, Kawai M, Naoi M,. 1994. Uptake of a neurotoxin-candidate, (R)-1,2-dimethyl-6,7-dihydroxy-1,2,3,4- tetrahydroisoquinoline into human dopaminergic neuroblastoma SH-SY5Y cells by dopamine transport system. J Neural Transm Gen Sect 98 (2): 107-118.
25. Takano K, Kitao Y, Tabata Y, Miura H, Sato K, Takuma K, Yamada K, Hibino S, Choshi T, Iinuma M, Suzuki H, Murakami R, Yamada M, Ogawa S, Hori O,. 2007. A dibenzoylmethane (DBM) derivative protects dopaminergic neurons against both oxidative stress and endoplamic reticulum (ER) stress. Am J Physiol Cell Physiol 293 (6): C1884-C1894.
26. Wagner AE, Boesch-Saadatmandi C, Breckwoldt D, Schrader C, Schmelzer C, Döring F, Hashida K, Hori O, Matsugo S, Rimbach G,. 2011. Ascorbic acid partly antagonizes resveratrol mediated heme oxygenase-1 but not paraoxonase-1 induction in cultured hepatocytes-Role of the redox-regulated transcription factor Nrf2. BMC Complement Altern Med 11: 1.
27. Watanabe MA, Amarante MK, Conti BJ, Sforcin JM,. 2011. Cytotoxic constituents of propolis inducing anticancer effects: A review. J Pharm Pharmacol 63 (11): 1378-1386. doi: 10.1111/j.2042-7158.2011.01331.x. Epub2011 Sep 27.